All
Q & A: No more frizz!: Moisturizers for rosacea patients, anti-frizz product ingredients revealed
January 1st 2009Rosacea patients comprise the biggest group of individuals with sensitive skin. This sensitive skin is thought to be due, in part, to a defective barrier and vasomotor instability. Thus, any topically applied substance that causes noxious sensory stimuli, vasodilation or irritation can result in a rosacea flare.
Rosacea: Lasers, lights play role in treatment of some subtypes
January 1st 2009Rosacea is a common skin disorder that affects 14 million Americans. Though the condition is sometimes mild in nature, many patients with rosacea have lower self-esteem and tend to avoid public contact or cancel social engagements.
Inside job: Nutricosmetics help body fight aging from within
January 1st 2009Today, many consumers are choosing to fight aging from the inside by using nutricosmetics, such as drinks, supplements and foods that claim to slow the visible signs of aging. But some precautions are in order, according to one expert.
Triple teaming: Lights, fillers, Botox tackle signs of aging
January 1st 2009Both ablative and nonablative technologies can rejuvenate the skin. They can also be used to treat acne scarring. Nonablative technologies like intense pulsed light can treat brown spots and control redness associated with rosacea.
Finding consensus: Simplified classification of cicatricial alopecia needed
January 1st 2009Finding a consensus on the classification of cicatricial alopecia can help physicians better communicate with each other. Quicker recognition of disease will allow patients to be treated earlier and improve treatment outcomes.
Tinea capitis: Unusual, rare presentations mimic cicatricial alopecia
January 1st 2009Unusual and rare presentations of tinea capitis can sometimes mimic cicatricial alopecia. According to one expert, it is important to consider all possible diagnoses and especially rule out a fungal scalp disease, no matter how suspicious the clinical presentation may be.
Cicatricial alopecia: Working classification, treatment protocols bring hope
January 1st 2009Arlington, Va. - Little is known about the obscure disease group of alopecias known as cicatricial alopecia, or scarring alopecia, and to date, an effective therapy for this hair loss disease group largely remains elusive. According to one expert in the field, diagnosing the disease early is key to halting or slowing the progression of the hair loss.
Guest commentary: Disease management: Skin cancer incidence, prevalence on the rise
January 1st 2009During the Congress of the European Academy of Dermatology and Venereology, the European Society for Micrographic Surgery discussed the growing problem of skin cancer. We would like to share our thoughts about the increasing number of skin cancer patients and how to deal with this problem.
FDA holds off decision on psoriasis drug
December 24th 2008New York - The Food and Drug Administration (FDA) has held off making a decision on the psoriasis drug ustekinumab (Johnson & Johnson), until they receive certain risk-mitigation information, but will not require new studies, Reuters reports.
Out of Africa: U.S. derm seeks volunteers for telemedicine project to help countries in need
December 8th 2008U.S. dermatologist Carrie Kovarik, M.D., along with the help of the AAD, has built a successful telecommunication program linking dermatologists in developed countries with clinicians who need advice and consultation to help patients throughout Africa. Plans are for the program to expand in and outside Africa, into Central and South Americas.